MSCs were trypsinized and placed in a 12-well plate or a 24-well plate at a density of 4000 cells/cm2. The cells were incubated in α-MEM medium for three or four days. When over 80% confluence was reached, the medium was then replaced by an osteogenic induction medium (OIM) containing 1 nM dexamethasone, 20 mM beta-glycerophosphate, and 50 μM ascorbic acid. MSCs were treated for two weeks. The osteogenic differentiation was evaluated by real time qRT-PCR after 11 days and Alizarin Red staining at day 3, day 5, day 7 and day 11. Triplicate tests were conducted in each experiment.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.